Article
cDNA analysis demonstrates that the BRCA2 intronic variant IVS4-12del5 is a deleterious mutation.
Mutation research - 26 Apr 2009
Zhang Liying, Bacares Ruben, Boyar Sherry, Hudis Clifford, Nafa Khedoudja, Offit Kenneth
Abstract excerpt
Mutation screening of the breast and ovarian cancer predisposition genes BRCA1 and BRCA2 is becoming an increasingly important part of clinical practice. Classification of rare non-truncating sequence variants in the BRCA1 and BRCA2 genes is problematic because it is not known whether these subtle changes alter function sufficiently to predispose cells to cancer development. Several studies have reported the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
